Department for Physiology, VU University Medical Center, Institute for Cardiovascular Research, Amsterdam, the Netherlands.
Thromb Haemost. 2010 Jan;103(1):40-55. doi: 10.1160/TH09-06-0403. Epub 2009 Sep 30.
In the past decade understanding of the role of the Rho GTPases RhoA, Rac1 and Cdc42 has been developed from regulatory proteins that regulate specific actin cytoskeletal structures - stress fibers, lamellipodia and filopodia - to complex integrators of cytoskeletal structures that can exert multiple functions depending on the cellular context. Fundamental to these functions are three-dimensional complexes between the individual Rho GTPases, their specific activators (GEFs) and inhibitors (GDIs and GAPs), which greatly outnumber the Rho GTPases themselves, and additional regulatory proteins. By this complexity of regulation different vasoactive mediators can induce various cytoskeletal structures that enable the endothelial cell (EC) to respond adequately. In this review we have focused on this complexity and the consequences of Rho GTPase regulation for endothelial barrier function. The permeability inducers thrombin and VEGF are presented as examples of G-protein coupled receptor- and tyrosine kinase receptor-mediated Rho GTPase activation, respectively. These mediators induce complex but markedly different networks of activators, inhibitors and effectors of Rho GTPases, which alter the endothelial barrier function. An interesting feature in this regulation is that Rho GTPases often have both barrier-protecting and barrier-disturbing functions. While Rac1 enforces the endothelial junctions, it becomes part of a barrier-disturbing mechanism as activator of reactive oxygen species generating NADPH oxidase. Similarly RhoA is protective under basal conditions, but becomes involved in barrier dysfunction after activation of ECs by thrombin. The challenge and promise lies in unfolding this complex regulation, as this will provide leads for new therapeutic opportunities.
在过去的十年中,人们对 Rho GTPases RhoA、Rac1 和 Cdc42 的作用的理解已经从调节特定肌动蛋白细胞骨架结构(应力纤维、片状伪足和丝状伪足)的调节蛋白发展为细胞骨架结构的复杂整合器,这些整合器可以根据细胞环境发挥多种功能。这些功能的基础是单个 Rho GTPases 与其特定的激活剂(GEFs)和抑制剂(GDIs 和 GAPs)之间的三维复合物,这些复合物的数量远远超过 Rho GTPases 本身和其他调节蛋白。通过这种调节的复杂性,不同的血管活性介质可以诱导多种细胞骨架结构,使内皮细胞(EC)能够充分响应。在这篇综述中,我们重点介绍了这种复杂性以及 Rho GTPase 调节对内皮屏障功能的影响。凝血酶和 VEGF 等通透性诱导剂分别被视为 G 蛋白偶联受体和酪氨酸激酶受体介导的 Rho GTPase 激活的范例。这些介质诱导复杂但明显不同的 Rho GTPases 激活剂、抑制剂和效应器网络,从而改变内皮屏障功能。这种调节的一个有趣特征是 Rho GTPases 通常具有保护屏障和破坏屏障的双重功能。虽然 Rac1 加强内皮连接,但它作为 NADPH 氧化酶的活性氧生成的激活剂,成为破坏屏障机制的一部分。同样,RhoA 在基础条件下具有保护作用,但在凝血酶激活 EC 后,它会参与屏障功能障碍。挑战和希望在于揭示这种复杂的调节机制,因为这将为新的治疗机会提供线索。
Thromb Haemost. 2009-9-30
Cardiovasc Res. 2010-3-17
Circ Res. 2004-2-6
Nat Commun. 2025-7-7
Front Cell Dev Biol. 2024-7-11
Front Cell Dev Biol. 2023-9-14